UNITED
      STATES


SECURITIES
      AND EXCHANGE COMMISSION


Washington,
      D. C. 20549





FORM
      10-QSB/A


(Mark
      One)


x
            QUARTERLY
                REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
                1934





For
      the
      quarterly period ended March 31, 2007





o
            TRANSITION
                REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
                1934





For
      the
      transition period from ____________ to____________




Commission
      file number 000-51140




**CuraTech
      Industries, Inc.**


(Exact
      name of small business issuer as specified in its charter)


NEVADA
              
              87-0649332(State
                  or other jurisdiction of
              
              (I.R.S.
                  Employer identification No.)incorporation
                  or organization)
  6337
                  Highland Drive, No. 1053Salt
                  Lake City, Utah 84121(Address
                  of principal executive offices)


Issuer's
        telephone number: (801) 616-2355





Check
      whether the issuer (1) filed all reports required to be filed by Section 13
      or
      15(d) of the Exchange Act during the past 12 months (or for such shorter period
      that the registrant was required to file such reports), and (2) has been subject
      to such filing requirements for the past 90 days.




Yes x
      No o




Indicate
      by check mark whether the registrant is a shell company (as defined in Rule
      12b-2 of the Exchange Act).




Yes o
      No x




APPLICABLE
      ONLY TO CORPORATE ISSUERS





State
      the
      number of shares outstanding of each of the issuer’s classes of common stock, as
      of the latest practicable date: As of March 31, 2007, there were 16,802,387
      shares of the issuer’s common stock issued and outstanding.





Explanatory
      Note Regarding Amendment:





The
      Company’s Quarterly Report on Form 10-QSB for the period ended March 31, 2007
      originally filed on May 21, 2007 has been amended since the Company’s financial
      statements have been restated to: (a) properly account for the 2006 acquisition
      of MedaCure International, Inc. (“MedaCure”) by the Company as a reverse
      acquisition, with MedaCure presented as the accounting acquirer; and (ii) record
      the issuance of 890,000 shares of the Company’s common stock that were issued to
      various persons in first quarter 2007 pursuant to the Company’s Form S-8
      registration statement filed January 24, 2007. The information in this report
      is
      current as of March 31, 2007, unless otherwise specified.








**CURATECH
      INDUSTRIES, INC.**


**FORM
      10-QSB**





**TABLE
      OF CONTENTS**





**PART
      I - FINANCIAL INFORMATION**




**Page**Item
                  1.
              Financial
                  Statements (Unaudited)
              3Balance
                  Sheets — As of March 31, 2007 (Unaudited) and December 31, 2006
              5Statements
                  of Operations for the Three Months Ended March 31, 2007
                  (Unaudited)
              6Statements
                  of Cash Flows for the Three Months Ended March 31, 2007
                  (Unaudited)
              7Notes
                  to Financial Statements (Unaudited)
              8Item
                  2.
              Management’s
                  Discussion and Analysis or Plan of Operation
              10Item
                  3.
              Controls
                  and Procedures
              13**PART
                  II - OTHER INFORMATION**Item
                  1.
              Legal
                  Proceedings
              13Item
                  2.
              Unregistered
                  Sales of Equity Securities and Use of Proceeds
              13Item
                  3.
              Defaults
                  Upon Senior Securities
              14Item
                  4.
              Submission
                  of Matters to a Vote of Security Holders
              14Item
                  5.
              Other
                  Information
              14Item
                  6.
              Exhibits
                  and Reports on Form 8-K
              14





2


PART
      I -
      FINANCIAL INFORMATION





Item
      1.
      Financial Statements.





The
      unaudited balance sheets of CuraTech Industries, Inc., a Nevada corporation
      (“CuraTech” or the “Company”) (formerly Jump’n Jax, Inc.), as of March 31, 2007
      and December 31, 2006, the related unaudited statements of operations for the
      three month periods ended March 31, 2007, the related unaudited statements
      of
      cash flows for the three month periods ended March 31, 2007 and the notes to
      the
      unaudited financial statements follow. The financial statements have been
      prepared by CuraTech’s management in conformity with United States generally
      accepted accounting principles. In the opinion of management, all adjustments
      considered necessary for a fair presentation of the results of operations and
      financial position have been included and all such adjustments are of a normal
      recurring nature. Operating results for the period ended March 31, 2007, are
      not
      necessarily indicative of the results that can be expected for the year ending
      December 31, 2007.





The
      names
“CuraTech”, “we”, “our” and “us” used in this report refer to CuraTech
      Industries, Inc.





3




**CURATECH
      INDUSTRIES, INC.**




**INDEX
      TO FINANCIAL STATEMENTS**




PageBalance
                  Sheets - March 31, 2007 (Unaudited) and December 31, 2006
              5Statements
                  of Operations (Unaudited) for the Three Months Ended March 31,
                  2007
              6Statements
                  of Cash Flows (Unaudited) for the Three Months Ended March 31,
                  2007
              7Notes
                  to Financial Statements
              8




4




**CURATECH
                  INDUSTRIES, INC.**(Formerly
                  Jump'n Jax, Inc.)Balance
                  Sheets




ASSETSMarch
                31,
            
            December
                31,2007
            
            2006(Unaudited)CURRENT
                ASSETSCash
            
            $
            345,210
            
            $
            29,443Note
                receivable - related party
            
            
            61,324
            
            
            17,415Total
                Current Assets
            
            
            406,534
            
            
            46,858FIXED
                ASSETS, Net
            
            
            6,568
            
            
            6,811TOTAL
                ASSETS
            
            $
            413,102
            
            $
            53,669LIABILITIES
                AND STOCKHOLDERS' EQUITY (DEFICIT)CURRENT
                LIABILITIESAccounts
                payable
            
            $
            626
            
            $
            1,330Notes
                payable - related party
            
            
            -
            
            
            5,288Total
                Current Liabilities
            
            
            626
            
            
            6,618TOTAL
                LIABILITIES
            
            
            626
            
            
            6,618STOCKHOLDERS'
                EQUITY (DEFICIT)Common
                stock: 25,000,000 shares authorized;$0.001
                par value; 16,802,387 and 15,572,647shares
                issued and outstanding, respectively
            
            
            16,803
            
            
            15,573Additional
                paid-in capital
            
            
            2,517,490
            
            
            667,111Stock
                subscriptions receivable
            
            
            (123,250
            )
            
            (55,000
            )Accumulated
                deficit
            
            
            (1,998,567
            )
            
            (580,633
            )Total
                Stockholders' Equity (Deficit)
            
            
            412,476
            
            
            47,051TOTAL
                LIABILITIES AND STOCKHOLDERS'EQUITY
                (DEFICIT)
            
            $
            413,102
            
            $
            53,669




The accompanying notes are an integral part of these financial statements.


5
 
  **CURATECH
                    INDUSTRIES, INC.**(Formerly
                    Jump'n Jax, Inc.)Statements
                    of Operations
  For
                    the ThreeMonths
                    EndedMarch
                    31,2007REVENUES
                
                $
                -OPERATING
                    EXPENSESGeneral
                    and administrative
                
                
                1,389,789Consulting
                    expense
                
                
                28,300Total
                    Operating Expenses
                
                
                1,418,089LOSS
                    FROM OPERATIONS
                
                
                (1,418,089
                )OTHER
                    EXPENSESOther
                    income
                
                
                155Total
                    Other Expenses
                
                
                155LOSS
                    FROM CONTINUINGOPERATIONS
                
                
                (1,417,934
                )LOSS
                    FROM DISCONTINUEDOPERATIONS
                
                
                -NET
                    LOSS
                
                $
                (1,417,934
                )BASIC
                    LOSS PER SHARE
                
                $
                (0.09
                )Continuing
                    operations
                
                
                (0.09
                )Discontinued
                    operations
                
                
                0.00Total
                    Basic Loss Per Share
                
                
                (0.09
                )WEIGHTED
                    AVERAGE NUMBEROF
                    SHARES OUTSTANDING
                
                
                15,742,693
  The accompanying notes are an integral part of these financial statements.
 6
  **CURATECH
                    INDUSTRIES, INC.**(Formerly
                    Jump'n Jax, Inc.)Statements
                    of Cash Flows
  For
                    the ThreeMonths
                    EndedMarch
                    31,2007CASH
                    FLOWS FROM OPERATING ACTIVITIESNet
                    loss
                
                
                (1,417,934
                )Adjustments
                    to reconcile net loss tonet
                    cash used by operating activities:Common
                    stock issued for services
                
                
                1,335,000Services
                    contributed by officers
                
                
                7,000Net
                    assets of discontinued operations
                
                
                -Depreciation
                    expense
                
                
                243Impairment
                    of assets
                
                
                -Changes
                    in operating assets and liabilities:Decrease
                    in accounts payable
                
                
                (860
                )Decrease
                    in accrued expenses
                
                
                (5,287
                )Net
                    Cash Used by OperatingActivities
                
                
                (81,838
                )CASH
                    FLOWS FROM INVESTING ACTIVITIES
                
                
                -CASH
                    FLOWS FROM FINANCING ACTIVITIESCommon
                    stock issued for cash
                
                
                441,359Increase
                    in note receivable - related
                
                
                (43,754
                )Net
                    Cash Provided by OperatingActivities
                
                
                397,605NET
                    INCREASE IN CASH
                
                
                315,767CASH
                    AT BEGINNING OF PERIOD
                
                
                29,443CASH
                    AT END OF PERIOD
                
                $
                345,210CASH
                    PAID FOR:Interest
                
                $
                -Taxes
                
                $
                -
  The accompanying notes are an integral part of these financial statements.
 7




**CURATECH
        INDUSTRIES, INC.**
 (Formerly
        Jump’n Jax, Inc.)
 Notes
        to
        the Financial Statements (Continued)
 March
        31,
        2007 and December 31, 2006




NOTE
      1
      -  BASIS
      OF
      FINANCIAL STATEMENT PRESENTATION





The
      accompanying unaudited condensed financial statements have been prepared by
      the
      Company pursuant to the rules and regulations of the Securities and Exchange
      Commission. Certain information and footnote disclosures normally included
      in
      financial statements prepared in accordance with accounting principles generally
      accepted in the United States of America have been condensed or omitted in
      accordance with such rules and regulations. The information furnished in the
      interim condensed financial statements includes normal recurring adjustments
      and
      reflects all adjustments, which, in the opinion of management, are necessary
      for
      a fair presentation of such financial statements. Although management believes
      the disclosures and information presented are adequate to make the information
      not misleading, it is suggested that these interim condensed financial
      statements be read in conjunction with the Company's most recent audited
      financial statements and notes thereto included in its December 31, 2006 Annual
      Report on Form 10-KSB/A of the Company. Operating results for the three months
      ended March 31, 2007 are not necessarily indicative of the results that may
      be
      expected for the year ending December 31, 2007.





NOTE
      2
      -  GOING
      CONCERN





The
      Company's financial statements are prepared using accounting principles
      generally accepted in the United States of America applicable to a going concern
      which contemplates the realization of assets and liquidation of liabilities
      in
      the normal course of business. The Company has not established revenues
      sufficient to cover its operating costs and allow it to continue as a going
      concern. Management intends to increase operations through expanding its
      operations into other locals, in the interim, management and primary
      shareholders are committed to meeting the Company’s minimal operating
      expenses.





NOTE
      3
      -  COMMON
      STOCK TRANSACTIONS





During
      the first quarter of the 2007 calendar year, the Company issued 339,740 shares
      of common stock for cash and subscriptions receivable at $1.50 per share. In
      addition, the Company issued 890,000 shares of common stock for various
      professional services rendered at $1.50 per share.





In
      May
      2006, the Company issued 800,000 common shares to an unrelated third party
      in
      exchange for services rendered and $30,000 in cash.





In
      October 2006 the Company issued an aggregate of 12,342,239 shares of common
      stock as consideration for the acquisition of Medacure International,
      Inc.





NOTE
      4 -
      RELATED PARTY TRANSACTIONS





Since
      the
      Company’s acquisition of Medacure International, Inc. the Company has at various
      times made temporary loans to the Company’s Chief Executive Officer. The
      outstanding balance of these loans at March 31, 2007, including accrued
      interest, is $61,324.





NOTE
      5 -
      AGREEMENT AND PLAN OF MERGER





On
      October 26, 2006, the Company completed the acquisition of MedaCure
      International, Inc., a Nevada corporation located in Salt Lake City, Utah
      (“MedaCure”). The acquisition was consummated pursuant to an agreement entered
      into on June 22, 2006, whereby the Company agreed to merge its newly created,
      wholly-owned subsidiary, CuraTech Acquisitions, Inc., with and into MedaCure
      with MedaCure being the surviving entity as the Company’s wholly owned
      subsidiary.





8




**CURATECH
      INDUSTRIES, INC.**


(Formerly
      Jump’n Jax, Inc.)


Notes
      to
      the Financial Statements (Continued)


March
      31,
      2007 and December 31, 2006




NOTE
      5 -
      AGREEMENT AND PLAN OF MERGER (Continued)





Prior
      to
      completion of the acquisition, on October 4, 2006 the Company completed a
      forward stock split on a four shares for one share basis. In addition, the
      Company changed its corporate name to CuraTech Industries, Inc. As a result
      of
      the forward stock split, the Company’s outstanding shares of common stock
      increased from 807,602 shares to 3,230,408 shares. The Company also changed
      its
      corporate domicile from the State of Utah to Nevada. Additionally, per the
      terms
      of the Merger Agreement the Company issued an aggregate of 12,342,239 shares
      of
      its common stock, post-split, to the stockholders of MedaCure. Also, the Company
      added three new directors, each nominated by MedaCure, to its Board of
      Directors.





From
      the
      consummation of the Merger Agreement, the Company has begun the development
      and
      bringing to market a certain health supplement that is intended to enhance
      and
      build-up the body’s natural immune system defenses. The Company intends to
      commence commercial marketing of its supplement in the near future primarily
      outside the U.S. Initial marketing in the U.S. will primarily be to the
      veterinarian market for use in treating animals. The Company also intends to
      initiate a collaboration and partnering program that will focus on developing
      business alliances designed to generate sales, applications and marketing
      opportunities.





9


**CURATECH
      INDUSTRIES, INC.**


(Formerly
      Jump’n Jax, Inc.)


Notes
      to
      the Financial Statements (Continued)


March
      31,
      2007 and December 31, 2006


Item
      2.
      Management’s Discussion and Analysis or Plan of Operation.





The
      following information should be read in conjunction with the financial
      statements and notes thereto appearing elsewhere in this Form
      10-QSB.





**Recent
      Events**





On
      October 26, 2006, we completed the acquisition of MedaCure International, Inc.,
      a Nevada corporation located in Salt Lake City, Utah (“MedaCure”). The
      acquisition was consummated pursuant to an agreement entered into on June 22,
      2006, whereby we agreed to merge our newly created, wholly-owned subsidiary,
      CuraTech Acquisitions, Inc., with and into MedaCure with MedaCure being the
      surviving entity as our wholly owned subsidiary.





Prior
      to
      completion of the acquisition, on October 4, 2006 we effected a 4 shares for
      1
      share forward stock split of our issued and outstanding shares of common stock
      and changed our corporate name to CuraTech Industries, Inc. As a result of
      the
      forward stock split, our outstanding shares of common stock increased from
      807,602 shares to 3,230,408 shares. We have also changed our corporate domicile
      from the State of Utah to Nevada.





Under
      the
      terms of the merger agreement, we issued an aggregate of approximately
      12,342,239 shares of our common stock, post-split, to the stockholders of
      MedaCure. MedaCure is now a wholly-owned subsidiary of the Company. Also, we
      have added to our board of directors, three new directors nominated by MedaCure.
      The acquisition of MedaCure by the Company has been accounted for as a reverse
      acquisition, with MedaCure presented as the accounting acquirer.





During
      the three months ended March 31, 2007 the Company issued an aggregate of 890,000
      shares of common stock at $1.50 per share for services rendered, and an
      additional 339,740 shares of common stock for cash at $1.50 per share.





**Plan
      of Operation**





Following
      the completion of the acquisition of MedaCure, we have become engaged in the
      developing and marketing of MedaCure’s health supplement that is believed to
      enhance and build-up the body’s natural immune system defenses in both humans
      and animals. Our first priority will be to establish new facilities for our
      corporate headquarters and to manufacture product. Management is seeking at
      least a 5,000 square foot facility that can be leased on a long-term basis.
      The
      facility must have a sterile environment with an assembly line capable of
      mass-producing and packaging the product. The facility will also handle shipping
      of product and receiving materials. We have not selected a final site, but
      we
      have identified the necessary manufacturing equipment and packaging machinery
      needed. We estimate that the cost to prepare the site for operation will be
      approximately $150,000.




10




Contemporaneous
      with selecting the site for our operations, we will be creating a distribution
      network that will focus on initiating a collaboration and partnering program
      and
      developing business alliances designed to generate sales, applications and
      marketing opportunities. At present, we have not hired any sales or distribution
      personnel, but are in the process of initiating a search for qualified persons.
      We anticipate that during the next 12 months we will hire approximately 20
      persons, five for administrative duties, six for manufacturing and production,
      and nine for sales and marketing.





We
      estimate that during the next 12 months we will need approximately $600,000
      to
      establish our manufacturing facility, establish a sales and distribution
      network, commence production of the MedaCure product and begin selling
      activities. We have already raised approximately $500,000 of this amount. We
      anticipate that the source of the remaining funds needed will be from the
      private sale of securities and/or other financing activities conducted by our
      officers and directors. We anticipate that we will be able to raise
      approximately $1.5 million more by December 31, 2007.





**Inflation**





In
      the
      opinion of management, inflation has not and will not have a material effect
      on
      our operations in the immediate future. Management will continue to monitor
      inflation and evaluate the possible future effects of inflation on our business
      and operations.





**Results
      of Operations**





Three
      Months Ended March 31, 2007.





Revenues
      from continuing operations for the three month period ended March 31, 2007
      were
      $-0- . There is no comparable period one year earlier since the acquisition
      of
      MedaCure by CuraTech has been accounted for as a reverse acquisition in which
      MedaCure is treated as the acquirer for accounting purposes. MedaCure was only
      recently formed in April 2006. This lack of revenues was due primarily to the
      fact that we ceased our bounce house operations during the 2005 fiscal year,
      and
      our revenue stream pertaining to the Medacure subsidiary has not yet been
      sufficiently developed.





Total
      operating expenses for the three month period ended March 31, 2007 were
      $1,418,089. The operating expenses consist of $1,389,789 in general and
      administrative expenses due to costs and professional fees associated with
      the
      Medacure acquisition and filing requirements during the period,, and $28,300
      in
      consulting expense. The general and administrative expenses were paid for
      primarily through the issuance of 890,000 shares of common stock at $1.50 per
      share, for an aggregate expense of $1,335,000.





We
      reported a net loss of $1,417,934 for the three months ended March 31, 2007.
      The
      net loss is primarily attributed to the substantial general and administrative
      expenses incurred during the quarter ended March 31, 2007 for costs and
      professional fees associated with the Medacure acquisition and also for
      compliance with filing requirements during the period. These expenses were
      paid
      for primarily through the issuance of 890,000 shares of common stock at $1.50
      per share, for an aggregate expense of $1,335,000.





**Liquidity
      and Capital Resources**




11




At
      March
      31, 2007, we had cash on hand of $345,210 compared to $29,443 as of December
      31,
      2006. We believe that current cash on hand is not sufficient to satisfy our
      cash
      requirements for the next twelve months, which we estimate to be approximately
      $600,000. Due to the fact that our limited operations have not generated cash
      flow sufficient to cover ongoing business expenses and/or we purchase additional
      equipment, we may have to rely on our directors, or on outside sources, to
      provide additional funds. However, we have no agreements with anyone to provide
      future funds to our Company. If our directors are unable to provide future
      funding, if the need arises, we may have to look at alternative sources of
      funding. We do not have any firm plans as to the source of this alternative
      funding and there is no assurance that such funds will be available or, that
      even if they are available, that they will be available on terms that will
      be
      acceptable to us. In the event we are unable to secure necessary future funding,
      we may have to curtail our business or cease operations completely.





At
      March
      31, 2007, we had total assets of $413,102 and stockholders' equity of $412,476,
      compared to total assets of $53,669 and total stockholders' equity of $47,051
      at
      December 31, 2006.





**Net
      Operating Loss**





We
      have
      accumulated approximately $92,800 of net operating loss carryforwards as of
      March 31, 2007, which may be offset against taxable income and income taxes
      in
      future years. The use of these losses to reduce future income taxes will depend
      on the generation of sufficient taxable income prior to the expiration of the
      net operating loss carryforwards. The carry-forwards expire in the year 2027.
      In
      the event of certain changes in control, there will be an annual limitation
      on
      the amount of net operating loss carryforwards which can be used. No tax benefit
      has been reported in the financial statements for the year ended December 31,
      2007 because there is a 50% or greater chance that the carryforward will not
      be
      used. Accordingly, the potential tax benefit of the loss carryforward is offset
      by a valuation allowance of the same amount.





**Forward
      Looking and Cautionary Statements**





This
      report, including the sections entitled "Business," "Risk Factors" and
      "Management's Discussion and Analysis or Plan of Operations" contains
      forward-looking statements. These statements relate to future events or our
      future financial performance and involve known and unknown risks and
      uncertainties. These factors may cause our company's or our industry's actual
      results, levels of activity, performance or achievements to be materially
      different from those expressed or implied by the forward- looking statements.
      These risks and other factors include those listed under "Risk Factors" and
      elsewhere in this report. In some cases, you can identify forward-looking
      statements by terminology such as "may," "will" "should," "expects," "intends,"
      "plans," anticipates," "believes," "estimates," "predicts," "potential,"
      "continue," or the negative of these terms or other comparable
      terminology.





You
      should be aware that a variety of factors could cause actual results to differ
      materially from the anticipated results or other matters expressed in
      forward-looking statements. These risks and uncertainties, many of which are
      beyond our control, include:





*  the
      sufficiency of existing capital resources and our ability to raise additional
      capital to fund cash requirements for future operations;





*  uncertainties
      following any successful acquisition or merger related to the future rate of
      growth of our business and acceptance of our products and/or services;





*  volatility
      of the stock market, particularly within the technology sector; and





*  general
      economic conditions.





Although
      we believe the expectations reflected in these forward-looking statements are
      reasonable, such expectations cannot guarantee future results, levels of
      activity, performance or achievements.




12




You
      are
      cautioned that any forward-looking statements are not guarantees of future
      performance and are subject to risks and uncertainties. Actual results may
      differ materially from those included within the forward-looking statements
      as a
      result of various factors. Cautionary statements in the risk factors section
      and
      elsewhere in this report identify important risks and uncertainties affecting
      our future, which could cause actual results to differ materially from the
      forward-looking statements made in this report.





Item
      3.  Controls
      and Procedures.





Under
      the
      supervision and with the participation of management, our principal executive
      officer and principal financial officer evaluated the effectiveness of the
      design and operation of our disclosure controls and procedures, as defined
      in
      Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934
      (“Exchange Act”), as of March 31, 2007. Based on this evaluation, our principal
      executive officer and our principal financial officer concluded that, as of
      the
      end of the period covered by this report, our disclosure controls and procedures
      were effective and adequately designed to ensure that the information required
      to be disclosed by us in the reports we submit under the Exchange Act is
      recorded, processed, summarized and reported within the time periods specified
      in the applicable rules and forms and that such information was accumulated
      and
      communicated to our chief executive officer and chief financial officer, in
      a
      manner that allowed for timely decisions regarding required
      disclosure.





During
      the last fiscal quarter ended March 31, 2007, there has been no change in
      internal control over financial reporting that has materially affected, or
      is
      reasonably likely to materially affect our internal control over financial
      reporting.





ANY
      FORWARD-LOOKING STATEMENTS INCLUDED IN THIS FORM 10-QSB REPORT REFLECT
      MANAGEMENT = S
      BEST
      JUDGMENT BASED ON FACTORS CURRENTLY KNOWN AND INVOLVE RISKS AND UNCERTAINTIES.
      ACTUAL RESULTS MAY VARY MATERIALLY.





PART
      II -
      OTHER INFORMATION





Item
      1.
      Legal Proceedings.





There
      are
      no material pending legal proceedings to which we or our subsidiary is a party
      or to which any of our property is subject and, to the best of our knowledge,
      no
      such action against us is contemplated or threatened.




Item
      2.
      Unregistered Sales of Equity Securities and Use of Proceeds.




13




During
      the three month period ended March 31, 2007, The Company has not sold any shares
      of its common stock without registration under the Securities Act of 1933,
      except for the following:





(1)  The
      Company issued an aggregate of 339,740 shares of common stock to approximately
      32 persons at the sales price of $1.50 per share cash. The shares were issued
      without registration pursuant to Section 4(2) of the Securities Act of 1933
      and/or Rule 506 of Regulation D for transactions not involving any public
      offering. Each purchaser represented that he was acquiring the shares with
      investment intent, and the certificates representing the shares were given
      a
      restricted legend.





Item
      3.
      Defaults Upon Senior Securities.





None;
      not
      applicable.





Item
      4.
      Submission of Matters to a Vote of Security Holders.





None;
      not
      applicable.





Item
      5.
      Other Information.




None;
      not
      applicable.





Item
      6.
      Exhibits and Reports on Form 8-K.




(a)
            Exhibits.  Exhibit
              Number
            
            
            
            Description  31.1
            
            
            
            Certification
                of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley
                Act of 2002





31.2
            
            
            
            Certification
                of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley
                Act of 2002




32.1
            
            
            
            Certification
                of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley
                Act of 2002





32.2
            
            
            
            Certification
                of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley
                Act of 2002





(b)
      Reports on Form 8-K.




14




CuraTech
      filed one Current Report on Form 8-K during the quarter ended March 31, 2007.
      It
      was filed on January 5, 2007. It contained a disclosure under Item 5.02 that
      Steven D. Moulton resigned as a director on January 4, 2007. It also contained
      a
      disclosure that the number of shares of the Company’s common stock being
      registered on a Form S-8 registration statement was being increased to 890,000
      shares.





15


SIGNATURES





In
      accordance with the requirements of the Securities Exchange Act of 1934, the
      registrant has duly caused this report to be signed on its behalf by the
      undersigned thereunto duly authorized.




CURATECH INDUSTRIES, INC.Date: September 26, 2007
            By:
            /s/
              Lincoln M. DastrupLincoln
              M. DastrupPresident,
                Chief Executive Officer, Chief
              Financial
                Officer and Chief Accounting
              Officer




16